XML 41 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-based Compensation Expense (Tables)
9 Months Ended
Sep. 30, 2020
Summary of Stock Option Activity

Stock options granted by the Company typically vest over a four-year period and have a ten year contractual term. The following table summarizes the Company’s stock option activity under the 2019 Plan and 2016 Plan since December 31, 2019:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Remaining

Contractual

Term

(in years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding at December 31, 2019

 

 

2,023,828

 

 

$

9.31

 

 

 

8.94

 

 

$

2,730,209

 

Granted

 

 

1,032,506

 

 

 

15.73

 

 

 

 

 

 

 

 

 

Exercised

 

 

(118,281

)

 

 

7.59

 

 

 

 

 

 

 

 

 

Cancelled

 

 

(69,360

)

 

 

12.23

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2020

 

 

2,868,693

 

 

$

11.62

 

 

 

8.73

 

 

$

425,192

 

Exercisable at September 30, 2020

 

 

733,937

 

 

$

10.16

 

 

 

8.41

 

 

$

181,578

 

Weighted Average Assumptions Used to Calculate Fair Value of Stock Option The fair value of stock options granted during the three and nine months ended September 30, 2020 and 2019 under the 2019 Plan and the 2016 Plan has been calculated on the date of grant using the following weighted average assumptions:

 

 

 

Three Months

Ended

September 30, 2020

 

 

Three Months

Ended

September 30, 2019

 

 

Nine Months

Ended

September 30, 2020

 

 

Nine Months

Ended

September 30, 2019

 

Risk-free interest rate

 

 

0.3

%

 

 

1.7

%

 

 

1.4

%

 

 

2.4

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Expected term (years)

 

 

6.0

 

 

 

6.0

 

 

 

6.0

 

 

 

6.0

 

Expected stock price volatility

 

 

78.1

%

 

 

80.1

%

 

 

75.9

%

 

 

81.0

%

 

Summary of Stock-Based Compensation Expense Recognized

The total compensation cost recognized in the statements of operations associated with all stock-based compensation awards granted by the Company is as follows (in thousands):

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Research and development

 

$

779

 

 

$

533

 

 

$

2,723

 

 

$

1,398

 

General and administrative

 

 

997

 

 

 

646

 

 

 

2,950

 

 

 

1,552

 

Total stock-based compensation expense

 

$

1,776

 

 

$

1,179

 

 

$

5,673

 

 

$

2,950

 

2019 Plan and 2016 Plan  
Summary of Restricted Stock Activity

The shares of common stock underlying restricted stock awards typically vest over a four-year period. The shares of common stock are recorded in stockholders’ equity as they vest.

The following table summarizes the Company’s restricted stock activity under the 2019 Plan and 2016 Plan since December 31, 2019:

 

 

 

Number of

Shares

 

 

Weighted

Average Grant

Date Fair

Value

 

Unvested at December 31, 2019

 

 

346,423

 

 

$

3.05

 

Granted

 

 

 

 

 

 

Vested

 

 

(198,343

)

 

 

2.99

 

Repurchased

 

 

(24,010

)

 

 

3.02

 

Unvested at September 30, 2020

 

 

124,070

 

 

$

3.15

 

Grants Outside of 2016 Stock Incentive Plan and 2019 Stock Incentive Plan  
Summary of Restricted Stock Activity

The following table summarizes the Company’s restricted stock activity outside of the 2019 Plan and 2016 Plan since December 31, 2019:

 

 

 

Number of

Shares

 

 

Weighted

Average Grant

Date Fair

Value

 

Unvested at December 31, 2019

 

 

334,647

 

 

$

2.94

 

Granted

 

 

 

 

 

 

Vested

 

 

(277,504

)

 

 

2.94

 

Repurchased

 

 

 

 

 

 

Unvested at September 30, 2020

 

 

57,143

 

 

$

2.94